ANIP PEER ANALYSIS

ANI Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

ANIPANI Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

ANIPIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ANIP	BHC	ECILC	ROVI	GENIL	HLN	Ind. Median
P/E	20.67●	—	—	22.08	46.82	31.28	21.37
P/B	3.30	-0.88●	0.80	4.32	3.47	1.98	1.82
EV/EBITDA	7.97	4.05●	33.84	14.64	14.07	19.15	12.26
P/S	2.01	0.21●	5.03	3.93	1.86	3.94	2.09

Financial Health
Metric	ANIP	BHC	ECILC	ROVI	GENIL	HLN	Ind. Median
Current Ratio	3.12	1.32	1.73	3.66●	1.33	0.92	2.22
Debt/Equity	58.3%	-1,010.0%●	5.9%	17.0%	41.0%	52.3%	46.3%
NetDebt/EBITDA	0.07	3.71	-0.10●	0.09	1.10	3.50	1.24

Profitability
Metric	ANIP	BHC	ECILC	ROVI	GENIL	HLN	Ind. Median
Net Margin	9.7%	-13.5%	-3.6%	17.8%●	4.0%	12.6%	4.0%
ROE	17.8%	—	-0.6%	20.9%●	8.7%	6.3%	6.4%
ROA	6.6%	-4.7%	-0.5%	15.1%●	4.8%	3.2%	3.4%
EBITDA Margin	25.4%	60.0%●	14.8%	27.0%	14.3%	25.2%	18.2%

Growth + Dividend
Metric	ANIP	BHC	ECILC	ROVI	GENIL	HLN	Ind. Median
Rev. Growth	37.0%●	-9.9%	-2.3%	-3.4%	16.3%	-26.7%	7.5%
NI Growth	—	—	—	-5.9%	146.6%●	-14.2%	5.0%
Div. Yield	0.0%	0.0%	2.6%●	1.6%	0.0%	2.0%	2.0%
Payout	0.8%	0.0%	-365.1%	36.3%	0.0%	40.0%	0.8%

Valuation
Metric	ANIP	AMLX	HROW	PRGO	COLL	XERS	Ind. Median
P/E	20.67	—	—	—	19.80●	122.48	21.37
P/B	3.30	7.39	55.43	0.61●	4.75	113.04	1.82
EV/EBITDA	7.97	—	57.12	—	3.07●	30.27	12.26
P/S	2.01	—	5.92	0.37●	1.86	4.67	2.09

Financial Health
Metric	ANIP	AMLX	HROW	PRGO	COLL	XERS	Ind. Median
Current Ratio	3.12	17.85●	2.48	2.72	1.71	2.12	2.22
Debt/Equity	58.3%	2.1%●	1,047.4%	152.3%	258.6%	286.9%	46.3%
NetDebt/EBITDA	0.07	1.86	6.55	-2.78●	0.63	-1.61	1.24

Profitability
Metric	ANIP	AMLX	HROW	PRGO	COLL	XERS	Ind. Median
Net Margin	9.7%●	—	-5.6%	-43.5%	9.4%	3.8%	4.0%
ROE	17.8%	-63.3%	-35.1%	-53.0%	27.4%●	—	6.4%
ROA	6.6%●	-58.5%	-3.8%	-20.5%	4.6%	3.4%	3.4%
EBITDA Margin	25.4%	—	11.7%	-29.7%	76.6%●	14.7%	18.2%

Growth + Dividend
Metric	ANIP	AMLX	HROW	PRGO	COLL	XERS	Ind. Median
Rev. Growth	37.0%	—	26.2%	-3.6%	19.9%	41.5%●	7.5%
NI Growth	—	—	—	—	70.7%	—	5.0%
Div. Yield	0.0%	—	—	11.3%●	—	—	2.0%
Payout	0.8%	—	—	-8.7%	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ANIP

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.